AVS (Amplitude Vascular Systems) is a company creating a new treatment option for pulsatile intravascular lithotripsy (PIVL), an emerging, minimally Read More


Calcified arterial disease device company AVS adds $8.8M to its Series B funding
AVS (Amplitude Vascular Systems) is a company creating a new treatment option for pulsatile intravascular lithotripsy (PIVL), an emerging, minimally Read More
Vascular calcification is a common condition that has been shown to increase the risk of major cardiovascular events, Read More